Posts by Maxx Chatsko
Article
What Makes a Biotech 10-Bagger?
Jun 21, 2021
You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective.
By Maxx Chatsko
Premium Advisor Update
Can Better Antibodies Challenge Cell Therapy?
Jun 14, 2021
By Maxx Chatsko
Video
Maxx’s Top Stock for June 2021
Jun 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets.
By Maxx Chatsko
Article
Thermodynamics and Long-Term Investing
May 22, 2021
There is a game. You have to play the game.
By Maxx Chatsko
Video
Maxx’s Top Stock for May 2021
May 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation.
By Maxx Chatsko
Article
Can the Bioeconomy Transform Argentina into a Regional Superpower?
Apr 22, 2021
Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked.
By Maxx Chatsko
Premium Advisor Update
Running with Scissors: Will CRISPR be Humbled in the Clinic?
Apr 13, 2021
By Maxx Chatsko
Podcast
AACR Annual Meeting 2021: What’s the Frontier of Cancer Research?
Apr 8, 2021
The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to...
By Daniel Kline
Video
Maxx’s Top Stock for April 2021
Apr 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers.
By Maxx Chatsko
Article
The Many Paths to Portfolio Allocation
Mar 22, 2021
Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation.
By Maxx Chatsko
Premium Advisor Update
My Long-Term Strategy in a Volatile Market
Mar 15, 2021
By Maxx Chatsko
Video
Maxx’s Top Stock for March 2021
Mar 1, 2021
Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars.
By Maxx Chatsko
Podcast
What FinTwit Isn’t Telling You About These Biotech Stocks
Feb 23, 2021
When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and...
By Manisha Samy
Article
A Mission Statement is Easy. Execution is Difficult
Feb 22, 2021
A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors.
By Maxx Chatsko
Premium Advisor Update
Most Investors Neglect One of Their Biggest Advantages
Feb 14, 2021
By Maxx Chatsko
Video
Maxx’s Top Stock for February 2021
Feb 1, 2021
7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development.
By Maxx Chatsko
Article
Genomics Isn’t the Only Omics
Jan 22, 2021
Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords.
By Maxx Chatsko
Premium Advisor Update
Will Renewable Energy Soar During the Biden Administration?
Jan 15, 2021
By Maxx Chatsko
Podcast
JPM 39th Annual Healthcare Conference: What We’re Watching
Jan 7, 2021
The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of...
By Manisha Samy
Video
Maxx’s Top Stock for January
Jan 1, 2021
7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic...
By Maxx Chatsko
Article
Does the “B” Word Apply? It’s Complicated
Dec 22, 2020
Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks.
By Maxx Chatsko
Podcast
ASH Conference Preview: What We’re Watching
Dec 3, 2020
7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference.
By Manisha Samy
Podcast
Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone
Dec 1, 2020
Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more.
By Maxx Chatsko
